======= PRKDC ======= == Gene Information == * **Official Symbol**: PRKDC * **Official Name**: protein kinase, DNA-activated, catalytic subunit * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5591|5591]] * **UniProt**: [[https://www.uniprot.org/uniprot/P78527|P78527]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PRKDC&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRKDC|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600899|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010]. * **UniProt Summary**: N/A No Pfam Domain information is available for this gene. |negative regulation of response to gamma radiation| |regulation of response to gamma radiation| |double-strand break repair via alternative nonhomologous end joining| |DNA-dependent protein kinase activity| |DNA-dependent protein kinase-DNA ligase 4 complex| |pro-B cell differentiation| |somatic diversification of T cell receptor genes| |immunoglobulin V(D)J recombination| |T cell receptor V(D)J recombination| |somatic recombination of T cell receptor gene segments| |B cell lineage commitment| |ectopic germ cell programmed cell death| |nonhomologous end joining complex| |programmed cell death involved in cell development| |negative regulation of immunoglobulin production| |lymphoid progenitor cell differentiation| |positive regulation of double-strand break repair via nonhomologous end joining| |V(D)J recombination| |negative regulation of cellular senescence| |telomere capping| |T cell lineage commitment| |regulation of double-strand break repair via nonhomologous end joining| |negative regulation of cell aging| |somatic recombination of immunoglobulin gene segments| |positive regulation of double-strand break repair| |spleen development| |negative regulation of production of molecular mediator of immune response| |somatic cell DNA recombination| |somatic diversification of immunoglobulins| |somatic diversification of immune receptors via germline recombination within a single locus| |regulation of cellular senescence| |protein-DNA complex| |thymus development| |protein destabilization| |T cell differentiation in thymus| |regulation of cell aging| |somatic diversification of immune receptors| |positive regulation of fibroblast proliferation| |response to gamma radiation| |signal transduction involved in mitotic DNA damage checkpoint| |signal transduction involved in mitotic cell cycle checkpoint| |signal transduction involved in mitotic G1 DNA damage checkpoint| |intracellular signal transduction involved in G1 DNA damage checkpoint| |signal transduction involved in mitotic DNA integrity checkpoint| |double-strand break repair via nonhomologous end joining| |mitotic G1 DNA damage checkpoint| |mitotic G1/S transition checkpoint| |non-recombinational repair| |G1 DNA damage checkpoint| |regulation of immunoglobulin production| |response to activity| |somitogenesis| |positive regulation of DNA repair| |intrinsic apoptotic signaling pathway in response to DNA damage| |signal transduction involved in DNA integrity checkpoint| |signal transduction involved in DNA damage checkpoint| |signal transduction involved in cell cycle checkpoint| |positive regulation of type I interferon production| |regulation of double-strand break repair| |regulation of fibroblast proliferation| |somite development| |hematopoietic progenitor cell differentiation| |mitotic DNA damage checkpoint| |segmentation| |telomere maintenance| |positive regulation of response to DNA damage stimulus| |telomere organization| |negative regulation of G1/S transition of mitotic cell cycle| |double-stranded DNA binding| |mitotic DNA integrity checkpoint| |signal transduction in response to DNA damage| |negative regulation of cell cycle G1/S phase transition| |B cell differentiation| |nuclear chromosome, telomeric region| |regulation of circadian rhythm| |negative regulation of immune effector process| |regulation of DNA repair| |regulation of type I interferon production| |DNA damage checkpoint| |regulation of smooth muscle cell proliferation| |T cell differentiation| |regulation of production of molecular mediator of immune response| |DNA integrity checkpoint| |intrinsic apoptotic signaling pathway| |response to ionizing radiation| |regulation of G1/S transition of mitotic cell cycle| |mitotic cell cycle checkpoint| |B cell activation| |immunoglobulin production| |cellular response to insulin stimulus| |regulation of cell cycle G1/S phase transition| |positive regulation of developmental growth| |peptidyl-serine phosphorylation| |production of molecular mediator of immune response| |double-strand break repair| |cell cycle checkpoint| |positive regulation of DNA metabolic process| |peptidyl-serine modification| |transcription factor complex| |negative regulation of mitotic cell cycle phase transition| |anterior/posterior pattern specification| |regulation of response to DNA damage stimulus| |DNA recombination| |response to insulin| |negative regulation of cell cycle phase transition| |T cell activation| |lymphocyte differentiation| |protein kinase activity| |protein domain specific binding| |cell fate commitment| |activation of innate immune response| |positive regulation of growth| |cellular response to peptide hormone stimulus| |rhythmic process| |apoptotic signaling pathway| |regulation of protein stability| |negative regulation of mitotic cell cycle| |negative regulation of cell cycle process| |cellular response to peptide| |regulation of developmental growth| |leukocyte differentiation| |regionalization| |transcription factor binding| |regulation of epithelial cell proliferation| |positive regulation of innate immune response| |anatomical structure homeostasis| |enzyme binding| |regulation of DNA metabolic process| |positive regulation of response to biotic stimulus| |protein serine/threonine kinase activity| |lymphocyte activation| |response to peptide hormone| |negative regulation of protein phosphorylation| |gland development| |regulation of mitotic cell cycle phase transition| |pattern specification process| |response to radiation| |negative regulation of immune system process| |negative regulation of phosphorylation| |regulation of cell cycle phase transition| |positive regulation of cytokine production| |regulation of innate immune response| |regulation of immune effector process| |response to peptide| |positive regulation of defense response| |DNA repair| |positive regulation of multi-organism process| |regulation of response to biotic stimulus| |heart development| |hemopoiesis| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of cell cycle| |negative regulation of protein modification process| |protein-containing complex| |mitotic cell cycle process| |cellular response to organonitrogen compound| |positive regulation of response to external stimulus| |cellular response to hormone stimulus| |hematopoietic or lymphoid organ development| |activation of immune response| |regulation of mitotic cell cycle| |chordate embryonic development| |positive regulation of apoptotic process| |immune system development| |positive regulation of programmed cell death| |embryo development ending in birth or egg hatching| |cellular response to nitrogen compound| |developmental process involved in reproduction| |regulation of growth| |mitotic cell cycle| |protein ubiquitination| |regulation of cytokine production| |positive regulation of cell death| |regulation of cellular response to stress| |brain development| |DNA metabolic process| |regulation of cell cycle process| |regulation of defense response| |innate immune response| |protein modification by small protein conjugation| |regulation of multi-organism process| |cellular response to DNA damage stimulus| |head development| |nucleolus| |positive regulation of immune response| |circulatory system development| |peptidyl-amino acid modification| |negative regulation of apoptotic process| |anatomical structure formation involved in morphogenesis| |negative regulation of programmed cell death| |response to hormone| |positive regulation of cell population proliferation| |apoptotic process| |leukocyte activation| |negative regulation of developmental process| |defense response to other organism| |protein phosphorylation| |embryo development| |central nervous system development| |protein modification by small protein conjugation or removal| |negative regulation of cell death| |cell cycle process| |response to organonitrogen compound| |negative regulation of cellular protein metabolic process| |programmed cell death| |cellular response to oxygen-containing compound| |chromosome organization| |cell activation| |response to nitrogen compound| |cell death| |regulation of response to external stimulus| |negative regulation of protein metabolic process| |epithelium development| |regulation of immune response| |positive regulation of immune system process| |response to abiotic stimulus| |regulation of cell cycle| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |phosphorylation| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |cell cycle| |defense response| |positive regulation of developmental process| |RNA binding| |reproductive process| |reproduction| |regulation of protein phosphorylation| |response to endogenous stimulus| |regulation of response to stress| |ATP binding| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of phosphorylation| |regulation of cell population proliferation| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |cell development| |regulation of immune system process| |regulation of cell death| |intracellular signal transduction| |cellular response to stress| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |immune response| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |membrane| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|-2.22| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|-2.19| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.16| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|-2.01| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2.01| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|-1.93| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|-1.9| |[[:results:exp360|Genistein 15μM R07 exp360]]|-1.84| |[[:results:exp19|Etoposide 1μM R00 exp19]]|-1.81| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|-1.75| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|-1.7| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.491| Global Fraction of Cell Lines Where Essential: N/A ^Tissue^Fraction Of Cell Lines Where Essential^ == Essentiality in NALM6 == * **Essentiality Rank**: 1637 * **Expression level (log2 read counts)**: 10.57 {{:chemogenomics:nalm6 dist.png?nolink |}}